Blog

CNN
–

The American Centers for Disease Control and Prevention is currently investigating five hospital admissions that took place in people who recently received a vaccine that occurs disease caused by the Chikungunya virus.

In a message posted on Tuesday on a vaccine information page for care providers, the CDC said that people, all 65 and older, were admitted to hospital for heart or neurological events after vaccination with IXCHIQ, the only Chikungunya vaccine that is currently a license in the United States.

CNN has contacted the CDC for comment.

Chikungunya virus is usually spread to people through the bite of an infected mosquito. Most adults do not receive the vaccine; it is sometimes Recommended for certain travelers with an increased risk to be exposed to the illness transferred by mosquitoes.

“This subject will be discussed during a coming meeting of the Advisory Committee for Immunization Practices (ACIP). Healthcare suppliers must discuss the benefits and risks of vaccination with individual travelers based on their age, destination, travel time and planned activities, ”said the online notification of the CDC in part.

The Chikungunya vaccine and the surveillance for side effects were originally planned to be discussed in an ACIP meeting on Wednesday, according to a draft meeting agenda, but that meeting was postponed.

Dr. William Schaffner, expert in infectious diseases at Vanderbilt University Medical Center and Acip Liaison, said that the CDC research is an example of the agency’s vaccine monitoring system “who work well and send a signal” in detecting rare events that may deserve further research.

“And of course, the CDC and the locals that take care of these patients are now working on it, which is completely appropriate. That is the way the system should work, “Schaffner said.

“Don’t forget that we are still trying to find out if this is a causal relationship or a casual relationship,” he said about the research, in which he is not immediately involved. ‘Let us not draw conclusions yet. That’s why they do the research. ”

The IXCHIQ vaccine, administered as a single dose in the muscle, contains a living, weakened version of the Chikungunya virus. The vaccine, made by the biotechnology company Valneva, was the first vaccine approved by the American Food and Drug Administration to prevent diseases caused by the Chikungunya virus. The approval, in November 2023, was for people aged 18 and older who run an increased risk of exposure to the Chikungunya virus.

“It is recommended in a very limited way of travelers who go to countries where a current outbreak of Chikungunya is virus infection, and also to travelers who have been going to countries who had experienced an outbreak in the last five years,” Schaffner said. “And also to Laboratori who work with the Chikungunya virus in the laboratory.”

A Valneva spokesperson said on Thursday morning in an e-mail statement that the company is aware that the CDC will assess the safety data of postmarketing as part of his routine vaccine surveillance.

“We understand from the CDC that at least four of these five people had also received other vaccines, and most of them had important underlying medical conditions. Valneva has not identified problems with the safety signal by safety monitoring after marketing, including periodic safety reports and routine signal detection activities, and the safety profile of IXCHIQ remains consistent with data from clinical tests, unchanged and positive, ”said the statement. “No changes have been observed in the established safety profile of clinical test, including participants who are monitored for more than three years after vaccination. Valneva continues to collaborate with health authorities to guarantee the highest standards of vaccine safety. ”

Prescribing information for the vaccine entry: “Vaccination with IXchiq can cause serious or long-term chikungunya-like side effects.”

Chikungunya virus circulates in tropical and subtropical areas. According to the CDC locally, infections have been reported in the United States. But fallen and outbreaks were identified in more than 100 countries in America, Africa, Asia, Europe and the Indian and the Pacific.

Symptoms of chikungunya infections are fever, joint pain, headache, muscle pain, joint growths or rashes, according to the CDC, and the best way to prevent Chikungunya is to avoid mosquito bites. There are currently no medicines to treat chikungunya, but infected people can feel better with rest, liquids and freely available drugs for pain and fever.

In Tuesday’s notification, the CDC said that common side effects after vaccination that took place in more than 10% of vaccinated people in clinical examinations tenderness, headache, fatigue, muscle pain, joint pain, fever and nausea include. In some people, “serious or long-term chikungunya-like side effects occurred”.

Chikungunya-like reactions include “fever, joint pain, headache, rash, and can also include cardiac and neurological disorders that were serious in two cases,” said Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, who was not involved in the clinical studies, in an e-mail Wednesday.

The notification of the CDC encouraged care providers to report all the side effects that can be caused by vaccination to the CDC/FDA vaccine processing events Reporting System (VAERS) “, by submitting a report online or using a PDF form.

“The robust vaccine safety monitoring system often identifies extremely rare adverse effects of vaccines after approval,” said Barouch, an expert in the field of infectious diseases that is not involved in the CDC research.

When the vaccine was approved in 2023, the FDA noted that its safety was evaluated in two clinical studies in North America, in which around 3,500 adults received a dose of the vaccine, with one study with around 1,000 participants who received a placebo. Severe Chikungunya-like side effects took place in 1.6% of the IXCHIQ recipients and none of the placebo receivers, according to the FDA.

• My daughter showed “mean girl” behavior that led to a meeting with the school dean.
• Ashamed and upset by her behavior, I feared for her future relationships.
• I had to remind myself that we had to keep modeling empathetic behavior at home.

My stomach turned around when the school Dean my husband and me called in a conference to discuss the daughter of our first degree Behavior with a different classmate.

In the meeting we learned that our daughter consistently left her classmate from group activities. For example, every time the girl sat down with our daughter during lunch, our daughter stood up and sat at another table.

Sadly saddened by this behaviorMy husband and I thought about our parenthood. Did we not emphasize kindness in our house and modeled empathy? How often have we told our daughter about times when we experienced bullying as children – that it hurt our feelings and left a lasting impact? Our daughter seemed to be touched by these heart-to-havocs, but her behavior turned out to be at school at school.

It was embarrassing for our daughter to act with her classmate, and it was a good memory that I can influenceI can’t have control over it.

Children are their own people, formed by a combination of factors

Of course my husband and I felt ashamed and humble through the choices of our daughter. Laughing Regina George’s character In “Mean Girls” we don’t want to raise a mean girl.

I am aware that my response to fear was based, I turned to some simple truths to get a better perspective. They are naturally selfish, Jillian Amodiotold a recognized social worker to Business Insider. “It is a survival skills, but sometimes a frustrating when they display behavior that we consider” unacceptable, inappropriate or socially paralyzing, “Amodio said.

Furthermore, children have “no perspective on the long game,” said Patty JohnsonA clinical psychologist. “Their ability to plan, organize and follow is short -sighted, while we parents tend to predict far into the future of our children’s life. If they have a TIFF at school with another student, the child can concentrate on the incident that took place, while parents can worry about how their child can get to life, making friends who are confused.”

I struggled not to see my daughter’s behavior as a character error instead of what it was – an immature person who learned to navigate in a difficult relationship. If adults are inclined to struggle in relationships – and our brains are much more mature – how can we expect children to get it right every time?

This was a good memory that my daughter’s comfortable behavior was not necessarily reflects my parenthood Or who would grow up.

I give room for her to talk to me about things that happen

“But it wasn’t alone!” My daughter defended. “I got up because another girl said,” Let’s sit there! “

Although my daughter’s behavior was unkind and unforgivable, the more I refused the layers, the more I discovered that her view of what happened was complex and was confused in her other relationships at school. She is not a natural born leader and often takes her instructions from others. While we discussed her behavior, I discovered that she usually responded and modeled it from her colleagues.

Continuous conversation at home helped my daughter change her attitude towards the girl she was catige for. When she found ways to take her in school activities, my husband and I cheered her thoughtfulness and celebrated. If they had a misunderstanding, she felt safe to bring it to me or my husband so that we could discuss it. That girl got the top of her guest list when my daughter’s birthday party arrived.

Although my first reaction was shame and fear, I finally learned to release it and offer my daughter a safe place to process the complexity of this relationship. Although it was a difficult situation, it helped us to lay a better foundation for trust and communication of parent-child and, I hope, grace for each other.